As the global demand for high-quality antiretroviral (ARV) medicines continues to rise, Cordium Pharmaceuticals Pvt. Ltd. has established itself as a reliable Indian pharmaceutical exporter supplying premium-quality Abacavir + Dolutegravir + Lamivudine Tablets to international healthcare markets.
This fixed-dose combination is extensively prescribed for the management of HIV-1 infection, offering effective viral suppression through a synergistic mechanism that targets multiple stages of the HIV replication cycle.
Whether you are a pharmaceutical importer, government procurement agency, NGO, hospital chain, or wholesale distributor, Cordium Pharmaceuticals delivers internationally compliant pharmaceutical solutions with dependable export support.
How Does Abacavir + Dolutegravir + Lamivudine Work?
The triple-drug formulation combines three scientifically proven antiretroviral agents to inhibit HIV replication through complementary mechanisms.
Abacavir – Reverse Transcriptase Inhibitor
Abacavir belongs to the Nucleoside Reverse Transcriptase Inhibitor (NRTI) class. After activation inside infected cells, it interferes with viral DNA synthesis by acting as a faulty nucleotide, stopping the virus from reproducing.
Dolutegravir – Integrase Inhibitor
Dolutegravir is an Integrase Strand Transfer Inhibitor (INSTI) that blocks the HIV integrase enzyme. This prevents viral DNA from integrating into human DNA, effectively halting viral multiplication.
Lamivudine – Reverse Transcriptase Blocker
Lamivudine is another NRTI that inhibits reverse transcriptase activity, further preventing HIV from producing new copies of itself.
Combined Therapeutic Action
The combination delivers multiple antiviral benefits:
- Suppresses HIV replication rapidly
- Prevents integration of viral DNA into host cells
- Lowers plasma viral load
- Supports immune recovery by improving CD4 cell counts
- Helps reduce the development of drug resistance when taken as prescribed
- Provides convenient once-daily dosing for improved adherence
Therapeutic Uses of Abacavir + Dolutegravir + Lamivudine
This fixed-dose antiretroviral combination is commonly used for:
✔ Management of HIV-1 infection
✔ Long-term antiretroviral therapy (ART)
✔ First-line treatment in eligible patients following clinical guidelines
✔ Maintaining undetectable viral load
✔ Improving immune system performance
✔ Reducing HIV-related complications and disease progression
Treatment should always be initiated and monitored by qualified healthcare professionals, with appropriate patient evaluation and safety screening.
Key Advantages
- Triple-action HIV treatment
- Once-daily oral administration
- Improved patient compliance
- Effective viral suppression
- High-quality generic formulation
- Cost-effective solution for institutional procurement
- Suitable for government and NGO HIV treatment programs where approved
Why Global Buyers Prefer Cordium Pharmaceuticals Pvt. Ltd.
Cordium Pharmaceuticals Pvt. Ltd. is recognized for delivering pharmaceutical products that meet international quality expectations.
Our Strengths
- WHO-GMP compliant manufacturing practices
- Stringent quality assurance systems
- Competitive export pricing
- Bulk manufacturing capability
- Private labeling services
- Contract manufacturing (Third-Party Manufacturing)
- Professional export documentation
- Reliable international logistics
- Dedicated support for pharmaceutical importers and distributors
Countries We Export To
We proudly supply pharmaceutical products across major regulated and emerging healthcare markets, including:
- 🇰🇪 Kenya
- 🇳🇬 Nigeria
- 🇬🇭 Ghana
- 🇵🇭 Philippines
- 🇻🇳 Vietnam
- 🇦🇪 UAE
- 🇸🇦 Saudi Arabia
- 🇺🇿 Uzbekistan
- 🇰🇿 Kazakhstan
- 🇺🇸 USA
- 🇬🇧 UK
- 🇿🇦 South Africa
Our experienced export team assists with documentation, regulatory support, logistics coordination, and timely global deliveries.
Applications for International Buyers
Our Abacavir + Dolutegravir + Lamivudine Tablets are supplied for:
- Pharmaceutical import companies
- Government tenders
- International healthcare projects
- Hospital procurement
- HIV treatment programs
- Institutional supply chains
- NGO procurement initiatives
- Wholesale pharmaceutical distribution
Why This Combination Remains in High Global Demand
Growing awareness of HIV management, expansion of public health initiatives, increasing access to antiretroviral therapy, and international procurement programs continue to drive demand for high-quality fixed-dose combination ARV medicines. Reliable manufacturers capable of maintaining consistent quality and uninterrupted supply remain preferred partners for healthcare organizations worldwide.
